Evidence map›Paper›PMID 41766299›Full record

ReviewCurrent opinion in HIV and AIDS2026

HIV controllers, lessons learnt from the lymphoid tissues.

Andrea Mastrangelo, Riddhima Banga, Matthieu Perreau

Abstract readReview
In one paragraph

Review in Current opinion in HIV and AIDS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrea MastrangeloDivisions of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Riddhima Banga
Matthieu Perreau

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe existence of HIV controllers offers the possibility of identifying specific immune-virological attributes associated with the control of HIV replication, possibly guiding the development of immunological interventions to achieve a functional cure. In the past few years, pioneering studies focused on the study of viral reservoir and immune responses in lymphoid tissues. In the present review, we propose to summarize their findings. RECENT

findingsThe mechanisms of HIV control in tissues may present peculiar features. Despite efficient viral suppression in vitro , HIV-specific CD8 T cells from lymphoid tissues express lower levels of the classical cytotoxic molecules (Granzyme B and Perforin) directly ex vivo , suggesting that alternative mechanism(s) may operate in these compartments. Interestingly, tissue-resident CD8 T cells from multiple tissues express an array of alternative granzymes, whose contribution to the control of HIV replication remains to be established. NK cells also display peculiar features in lymphoid tissues, including lower levels of classical cytotoxic molecules and increased expression of CXCR5, highlighting the complexity of tissue-specific immunity in the context of HIV. SUMMARY: The immunological mechanisms associated with the control of HIV replication in tissues remain to be fully identified and may involve multiple mediators acting through distinct mechanisms. Recent evidence suggests that the control of HIV replication in lymphoid tissues probably depends on an appropriate positioning of effector cells in the tissue microenvironment, and may be mediated by different mechanisms depending on the levels of viral production and the body compartment.

Indexed as

HIV-1HIV InfectionsLymphoid TissueAnimalsCD8-Positive T-LymphocytesHumansKiller Cells, NaturalVirus ReplicationcompartmentalizationGALTHIV persistencelymph nodeT-follicular helper cellstissue HIV reservoir

Identifiers

PMID41766299
PMCPMC13048320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.